Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
出版年份 2021 全文链接
标题
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
作者
关键词
-
出版物
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-12-29
DOI
10.1016/j.cgh.2021.12.034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Population screening for liver fibrosis: towards early diagnosis and intervention for chronic liver diseases
- (2021) Pere Ginès et al. HEPATOLOGY
- Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
- (2021) Ditlev Nytoft Rasmussen et al. JOURNAL OF HEPATOLOGY
- Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use
- (2021) Marie Decraecker et al. LIVER INTERNATIONAL
- Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
- (2020) Laurent Castera LIVER INTERNATIONAL
- Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?
- (2020) Francesco Giuseppe Foschi et al. Annals of Hepatology
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease
- (2020) Salvatore Petta et al. Clinical Gastroenterology and Hepatology
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
- (2020) Beth A. Davison et al. JOURNAL OF HEPATOLOGY
- Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease
- (2020) Margarita Papatheodoridi et al. JOURNAL OF HEPATOLOGY
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials
- (2019) Quentin M. Anstee et al. HEPATOLOGY
- Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
- (2019) Hannes Hagström et al. GASTROENTEROLOGY
- Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
- (2019) Miquel Serra-Burriel et al. JOURNAL OF HEPATOLOGY
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Cost‐effectiveness of non‐invasive screening for alcohol‐related liver fibrosis
- (2019) Lars Asphaug et al. HEPATOLOGY
- Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
- (2019) Sarah Shili‐Masmoudi et al. LIVER INTERNATIONAL
- High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study
- (2018) Llorenç Caballería et al. Clinical Gastroenterology and Hepatology
- Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease
- (2018) Maja Thiele et al. GASTROENTEROLOGY
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
- (2018) Laura Pimpin et al. JOURNAL OF HEPATOLOGY
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
- (2018) Elliot B Tapper et al. BMJ-British Medical Journal
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
- (2018) Elliot B Tapper et al. BMJ-British Medical Journal
- Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study
- (2018) Núria Fabrellas et al. PLoS One
- Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
- (2018) Donghee Kim et al. GASTROENTEROLOGY
- Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests
- (2018) Jack W O’Sullivan et al. BMJ-British Medical Journal
- Active Surveillance for Low-Risk Cancers — A Viable Solution to Overtreatment?
- (2017) Megan R. Haymart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis
- (2016) Maja Thiele et al. GASTROENTEROLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- The benefits of screening–and its harms
- (2016) Minna Johansson et al. LANCET
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
- (2015) D. J. Harman et al. BMJ Open
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started